欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4530/001
药品名称Empressin 40 IU/2ml Injektionslösung
活性成分
    • Argipressin acetate 1.0 IU/ml
剂型Solution for injection
上市许可持有人Orpha-Devel Handels und Vertriebs GmbH Wintergasse 85/1B A-3002 PURKERSDORF
参考成员国 - 产品名称Germany (DE)
Empressin 40 IU/2ml Injektionslösung
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Reverpleg 40 I.E./2 ml concentraat voor oplossing voor infusie
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Empesin 40 I.E./2 ml Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Empressin
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Empesin 40 SV/2ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Empesin 40 TV/ 2 ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      EMPESIN
    • Hungary (HU)
      EMBESYN 40 NE/2 ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Empressin
    • Czechia (CZ)
      Empression 40 IU/ 2 ml solution for injection
    • Romania (RO)
      Reverpleg 40 U.I./2 ml concentrat pentru soluţie perfuzabilă
    • Slovakia (SK)
      Embesin 40 IU/2 ml infúzny koncentrát
    • Slovenia (SI)
      Empesin 40 i.e./2 ml koncentrat za raztopino za infundiranje
    • Croatia (HR)
      Empressin 40 IU/2 ml koncentrat za otopinu za infuziju
许可日期2018/02/15
最近更新日期2024/10/28
药物ATC编码
    • H01BA06 argipressin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase